282 related articles for article (PubMed ID: 21802879)
21. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
22. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
[TBL] [Abstract][Full Text] [Related]
23. Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: another lost treatment option?
Kahan NR; Chinitz DP; Waitman DA; Dushnitzky D; Kahan E; Shapiro M
Ann Pharmacother; 2006 Dec; 40(12):2223-7. PubMed ID: 17105833
[TBL] [Abstract][Full Text] [Related]
24. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
[TBL] [Abstract][Full Text] [Related]
25. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
Killgore KM; March KL; Guglielmo BJ
Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
[TBL] [Abstract][Full Text] [Related]
27. Empiric treatment of uncomplicated UTI in women: wasting money when more is not better.
Kahan NR; Chinitz DP; Waitman DA; Kahan E
J Clin Pharm Ther; 2004 Oct; 29(5):437-41. PubMed ID: 15482387
[TBL] [Abstract][Full Text] [Related]
28. Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel.
Raz R; Okev N; Kennes Y; Gilboa A; Lavi I; Bisharat N
Isr Med Assoc J; 2000 Jun; 2(6):426-9. PubMed ID: 10897231
[TBL] [Abstract][Full Text] [Related]
29. [Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000): a multicenter study].
Smaoui H; Mahjoubi F; Boutiba I; Jouaihia W; Thabet L; Znazen A; Kammoun A; Mezghanni S; Triki O; Hammami A; Ben Hassen A; Kechrid A; Ben Redjeb S
Tunis Med; 2003 Jun; 81(6):390-4. PubMed ID: 14534944
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
31. [Urinary tract pathogens in uncomplicated lower urinary tract infections in women in Norway].
Jureen R; Digranes A; Baerheim A
Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2021-2. PubMed ID: 12934120
[TBL] [Abstract][Full Text] [Related]
32. Impact of Allergy and Resistance on Antibiotic Selection for Recurrent Urinary Tract Infections in Older Women.
Malik RD; Wu YR; Christie AL; Alhalabi F; Zimmern PE
Urology; 2018 Mar; 113():26-33. PubMed ID: 29196069
[TBL] [Abstract][Full Text] [Related]
33. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
[TBL] [Abstract][Full Text] [Related]
35. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture.
Nys S; van Merode T; Bartelds AI; Stobberingh EE
J Antimicrob Chemother; 2006 May; 57(5):955-8. PubMed ID: 16554337
[TBL] [Abstract][Full Text] [Related]
36. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
Rock W; Colodner R; Chazan B; Elias M; Raz R
Isr Med Assoc J; 2007 Nov; 9(11):803-5. PubMed ID: 18085038
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
[TBL] [Abstract][Full Text] [Related]
39. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
40. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
